Synopsys saw an improvement in its IBD SmartSelect Composite Rating Friday, from 94 to 96. This number matches some other key CANSLIM factors, like EPS and Relative Strength, both at 91.
The new rating shows the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria. The best stocks tend to have a 95 or better grade as they launch a significant move so be sure to keep that in mind when looking for the best stocks to buy and watch.
Synopsys is trading within the buy zone from a 364.09 entry from a cup without handle. It is doing its best to hold on while the market swings around the current banking crisis.
Looking For The Best Stocks To Buy And Watch? Start Here
The stock sports a 91 EPS Rating, which means its recent quarterly and annual earnings growth tops 91% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company reported a 9% earnings-per-share gain for Q1. Revenue growth came in at 7%, down from 11% in the prior quarter.
Synopsys holds the No. 5 rank among its peers in the Computer Software-Design industry group. PDF Solutions is the No. 1-ranked stock within the group.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
